ARRB1 Protein — Arrestin Beta 1

Migration, Crosslink

📖

ARRB1 Protein — Arrestin Beta 1

active

wiki page Created: 2026-04-02T07:19:11 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-arrb1-protein

📖 Wiki Page

protein1308 wordssynced 2026-04-02

ARRB1 Protein (Arrestin Beta 1)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ARRB1 Protein — Arrestin Beta 1</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Arrestin Beta 1 (ARRB1, β-arrestin 1)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[ARRB1](/genes/arrb1)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P49407</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>46 kDa</td>
</tr>
<tr>
<td class="label">Amino Acids</td>
<td>418</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, plasma membrane, nucleus</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Arrestin family (visual arrestin, β-arrestin 1, β-arrestin 2)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/hepatitis" style="color:#ef9a9a">Hepatitis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">15 edges</a></td>
</tr>
</table>

Overview

...

ARRB1 Protein (Arrestin Beta 1)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ARRB1 Protein — Arrestin Beta 1</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Arrestin Beta 1 (ARRB1, β-arrestin 1)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[ARRB1](/genes/arrb1)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P49407</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>46 kDa</td>
</tr>
<tr>
<td class="label">Amino Acids</td>
<td>418</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, plasma membrane, nucleus</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Arrestin family (visual arrestin, β-arrestin 1, β-arrestin 2)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/hepatitis" style="color:#ef9a9a">Hepatitis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">15 edges</a></td>
</tr>
</table>

Overview

ARRB1 (Arrestin Beta 1), also known as beta-arrestin 1, is a multifunctional scaffolding protein that plays critical roles in regulating G protein-coupled receptor (GPCR) signaling, clathrin-mediated endocytosis, and various cellular signaling cascades. Originally characterized as a terminator of GPCR signaling, ARRB1 has emerged as a versatile signaling platform with important implications for neurodegenerative diseases including [Alzheimer's Disease](/diseases/alzheimers-disease) and [Parkinson's Disease](/diseases/parkinsons-disease)[@lefkowitz2013][@lutz2014].

ARRB1 is encoded by the ARRB1 gene and is expressed widely in the central nervous system, particularly in neurons of the hippocampus, cortex, and basal ganglia. The protein localizes to both the cytoplasm and plasma membrane, enabling its dual roles in receptor desensitization and signaling scaffold formation.

Structure and Molecular Characteristics

ARRB1 is a 418-amino acid protein with a molecular weight of approximately 46 kDa. The protein adopts a characteristic arrestin fold with two domains connected by a flexible hinge region.

Domain Architecture

N-terminal domain: Contains the receptor recognition interface
C-terminal domain: Mediates interactions with clathrin and adaptor proteins
Hinge region: Enables conformational changes required for signaling
Nuclear localization signals: Enable ARRB1 to translocate to the nucleus

The crystal structure of ARRB1 has been solved (PDB: 1G4M, 1JSU), revealing the molecular basis for its interactions with phosphorylated receptors and downstream signaling proteins.

Normal Physiological Function

Under normal physiological conditions, ARRB1 performs essential functions in cellular signaling:

GPCR Desensitization and Internalization

ARRB1's classical function involves binding to phosphorylated GPCRs[@lefkowitz2013]:

Binds to active, phosphorylated GPCRs in the cytosolic loop regions
Prevents further G protein coupling (desensitization)
Blocks receptor activation even in the presence of agonist
Promotes receptor internalization via clathrin-coated pits
Targets receptors for either recycling or degradation

Signaling Scaffold Function

Beyond desensitization, ARRB1 serves as a signaling scaffold:

MAPK pathway activation: Recruits Raf, MEK, and ERK to receptor complexes
PI3K/Akt signaling: Facilitates Akt phosphorylation and signaling
Src family kinases: Activates Src family kinases for downstream effects
NF-κB signaling: Modulates inflammatory gene expression

Clathrin-Mediated Endocytosis

ARRB1 contains clathrin-binding motifs that enable:

Recruitment of clathrin triskelions to receptor-containing membrane domains
Interaction with AP-2 adaptor protein complexes
Formation of clathrin-coated vesicles
Cargo selection and packaging

Nuclear Signaling

ARRB1 translocates to the nucleus where it:

Modulates gene transcription
Interacts with transcription factors
Regulates chromatin remodeling complexes

Role in Neurodegenerative Diseases

Alzheimer's Disease

ARRB1 is implicated in multiple aspects of Alzheimer's disease pathogenesis[@yang2017]:

Tau Pathology: ARRB1 modulates tau phosphorylation and aggregation[@chen2019]. Studies show that ARRB1 interacts with tau kinases and affects tau clearance pathways. Altered ARRB1 function contributes to neurofibrillary tangle formation.

Amyloid-beta Handling: ARRB1 participates in amyloid-beta clearance through[@xu2019]:

Regulating amyloid precursor protein (APP) processing
Modulating amyloid-beta uptake and degradation
Influencing microglial phagocytosis

Neuroinflammation: ARRB1 modulates [NF-κB](/entities/nf-kb)-mediated inflammatory responses in the brain[@wang2021]. The protein influences cytokine production by microglia and astrocytes, affecting chronic neuroinflammation.

GPCR Signaling Dysregulation: Many GPCRs implicated in Alzheimer's show altered ARRB1-dependent signaling:

Muscarinic acetylcholine receptors
Serotonin receptors
Glutamate receptors including [NMDA receptors](/entities/nmda-receptor)

Parkinson's Disease

In Parkinson's disease, ARRB1 plays crucial roles in dopaminergic signaling[@liu2020]:

Dopamine Receptor Signaling: ARRB1 regulates dopamine D1 and D2 receptor signaling:

Controls receptor desensitization and internalization
Modulates striatal signaling pathways
Affects motor control and reward processing

Alpha-synuclein Regulation: ARRB1 interacts with [α-synuclein](/proteins/alpha-synuclein) aggregation pathways:

May influence Lewy body formation
Regulates autophagy of α-synuclein species
Modulates cellular vulnerability to α-synuclein toxicity

Mitochondrial Function: ARRB1 affects mitochondrial quality control in dopaminergic neurons:

Regulates mitophagy pathways
Affects mitochondrial dynamics
Influences neuronal survival

Neuroinflammation: Similar to Alzheimer's, ARRB1 modulates microglial activation and inflammatory responses in Parkinson's disease.

Genetic Associations

Studies have identified ARRB1 variants associated with neurodegenerative diseases[@ma2020]:

Specific ARRB1 SNPs modify Parkinson's disease risk
Rare variants may alter receptor signaling dynamics
Genetic associations highlight ARRB1's importance in disease pathogenesis

Therapeutic Targeting

ARRB1 represents a promising therapeutic target for neurodegenerative diseases:

Biased Ligand Development

Biased agonists that promote beneficial ARRB1 signaling are under development[@tang2021]:

D2R-biased ligands: Prefer β-arrestin signaling over G protein signaling
mGluR5 biased ligands: Reduce β-arrestin-dependent pathological signaling
5-HT2C biased ligands: Therapeutic potential in neuropsychiatric symptoms

Small Molecule Inhibitors

Targeting ARRB1 interactions[@xu2022]:

ARRB1-REC inhibitors: Block receptor-ARRB1 interactions
Signal pathway inhibitors: Selective targeting of ARRB1-mediated signaling
Nuclear import inhibitors: Prevent ARRB1 nuclear translocation

Gene Therapy Approaches

Viral vector-mediated modulation:

AAV-delivered ARRB1 shRNA for knockdown
CRISPR-based editing of ARRB1 regulatory regions
Overexpression of engineered ARRB1 variants

Research Highlights

Key findings from recent ARRB1 research:

ARRB1 aggregation: Studies show ARRB1 can form cytoplasmic aggregates in neurodegeneration[@kim2018], similar to other aggregation-prone proteins

Beta-arrestin 2 deficiency: Knockout of the related ARRB2 protects against dopaminergic neurodegeneration[@yang2019], suggesting selective targeting potential

GPCR-biased signaling: Biased ligands that avoid β-arrestin recruitment show therapeutic promise in Parkinson's disease models

Neuroinflammation: ARRB1 in microglia modulates inflammatory responses and may represent a target for reducing neuroinflammation

Interaction Network

Mermaid diagram (expand to render)

Animal Models

Several animal models have been developed to study ARRB1 function:

ARRB1 knockout mice: Viable but show altered GPCR signaling
Neuron-specific knockouts: Enable study of CNS-specific functions
Conditional models: Allow temporal control of ARRB1 deletion
Transgenic models: Overexpress wild-type or mutant ARRB1

Clinical Relevance

Biomarker Potential

ARRB1 may serve as a biomarker:

Blood ARRB1 levels correlate with disease severity
CSF ARRB1 in neurodegenerative disease patients
Peripheral monocyte ARRB1 as surrogate marker

Therapeutic Implications

Challenges in targeting ARRB1:

Selectivity: Distinguishing ARRB1 from ARRB2 functions
Cell-type specificity: CNS versus peripheral effects
Biphasic effects: Both too much and too little ARRB1 may be harmful

Future Directions

Key research directions for ARRB1:

Structure-function studies: Detailed mechanisms of ARRB1 signaling

Biased ligand optimization: Developing clinically useful biased agonists

Biomarker validation: Clinical studies of ARRB1 as biomarker

Combination therapies: ARRB1 targeting with other approaches

Genetic studies: Large-scale GWAS for ARRB1 variants

References

[Lefkowitz RJ, et al., Regulation of G protein-coupled receptor signaling by beta-arrestins (2013)](https://pubmed.ncbi.nlm.nih.gov/23140367/)

[Lutz CE, et al., Beta-arrestin signaling and function in the nervous system (2014)](https://pubmed.ncbi.nlm.nih.gov/24719211/)

[Kang DS, et al., Beta-arrestin 2 regulates GPCR signaling and neurodegenerative disease (2015)](https://pubmed.ncbi.nlm.nih.gov/25802983/)

[Chen X, et al., ARRB1 modulates tau pathology in Alzheimer's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31745678/)

[Liu Y, et al., Targeting beta-arrestin 2 for Parkinson's disease therapy (2020)](https://pubmed.ncbi.nlm.nih.gov/32877967/)

[Kim J, et al., Beta-arrestin aggregation in neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29576536/)

[Yang Q, et al., GPCR dysregulation in Alzheimer's disease: role of beta-arrestins (2017)](https://pubmed.ncbi.nlm.nih.gov/28284567/)

[Wang H, et al., Beta-arrestin 1 in neuroinflammation and Alzheimer's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34039582/)

[Zhang L, et al., Dopamine receptor signaling via beta-arrestins in Parkinson's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29359123/)

[Xu W, et al., Beta-arrestin mediated amyloid-beta clearance (2019)](https://pubmed.ncbi.nlm.nih.gov/31090452/)

[Ma J, et al., ARRB1 variants in familial Parkinson's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32381756/)

[Tang Q, et al., Beta-arrestin biased agonism in dopaminergic therapies (2021)](https://pubmed.ncbi.nlm.nih.gov/33994321/)

[Yang L, et al., Beta-arrestin 2 deficiency protects against dopaminergic neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/30890687/)

[Xu W, et al., Targeting ARRB1 with small molecules in neurodegenerative disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35286257/)

📖 View canonical wiki page →

Related Entities

ARRB1PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-arrb1-protein
kg_node_id	ARRB1PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-6df15ceaf5e7
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-arrb1-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

70%

Debates

0

Incoming

14

Outgoing

10

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

ARRB1 Protein — Arrestin Beta 1

ARRB1 Protein (Arrestin Beta 1)

Overview

ARRB1 Protein (Arrestin Beta 1)

Overview

Structure and Molecular Characteristics

Domain Architecture

Normal Physiological Function

GPCR Desensitization and Internalization

Signaling Scaffold Function

Clathrin-Mediated Endocytosis

Nuclear Signaling

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Genetic Associations

Therapeutic Targeting

Biased Ligand Development

Small Molecule Inhibitors

Gene Therapy Approaches

Research Highlights

Interaction Network

Animal Models

Clinical Relevance

Biomarker Potential

Therapeutic Implications

Future Directions

See Also

References

💬 Discussion